IN BRIEF: Indivior reconfirms 2024 outlook amid NY-listing decision
Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Reconfirms financial guidance for 2024 ahead of analyst ’teach-in’ event in New York. Indivior also on Thursday...
Thu, 23/05/2024 - 12:29